Treatment for Metastatic breast cancer

 Metastatic breast cancer is otherwise called stage 4 breast cancer where cancer has widely spread to the neighboring organs. The common organs to which breast cancer gets metastasized are the lungs, bones, brain and liver. The symptoms of metastatic breast cancer are developed based on the affected site or organ. However, the common metastatic breast cancer symptoms include back pain, numbness, persistent dry cough, pain in the chest region, poor appetite and trouble breathing.

If you have been diagnosed with breast cancer and your oncologist suspects metastatic breast cancer then it shall be confirmed after obtaining the imaging tests like PET Scan of the whole body, CT scan, whole-body bone scan, blood tests to evaluate cancer biomarkers and biopsy of the suspected area.

The objective of treating metastatic breast cancer is to diminish the tumor size by retarding its growth. The other aim of treating metastatic breast cancer is improving the patients' symptoms and decreasing fatality rates. In order to achieve the right treatment plan, your oncologist would need to evaluate the tumor's genetic make-up.

The treatment for metastatic breast cancer involves systemic therapy to destroy the cancer cells in multiple locations. Systemic therapy involves chemotherapy, radiation therapy and targeted therapy.  If the biopsy report results in Hormone positive, it implies the overexpression of reproductive hormones such as estrogen and progesterone, which boosts cancer cells' growth. For treating hormone-positive breast cancer, hormonal therapy will be included.

The HR-positive HER2 negative breast cancer tends to develop gradually compared to HR-negative breast cancer. Also, studies state that women diagnosed with this type of breast have better treatment outcomes within a short period. However, if not treated rightly with appropriate treatment options, there are high chances that the  HR positive breast cancer can reoccur in the future.

For treating hormone-positive breast cancer, hormonal therapy is combined with other breast cancer treatments such as targeted therapy. This medication called ribociclib is used in treating Hormone positive Human epidermal growth receptor 2 breast cancer. Ribociclib produces its action by inhibiting the cyclin dependent kinase 4 and 6 that plays a significant role in cell division. Thereby this medicine works to cease the abnormal cell division of cancerous cells into other parts of the body. Kryxana is one such product that consists of ribociclib as the primary constituent and it is available as a Kryxana 200mg tablet in the market.

Kryxana 200mg tablet is intended for oral use only and can be consumed with or without food. It is vital to monitor your liver and kidney functions before consuming Kryxana 200mg tablets to avoid any complications. If you are planning for pregnancy, it is better to discuss with your doctor and outweigh the risks and benefits. At the same time, it is advised to report to your doctor if you have a history of allergy to peanuts or soy products to prevent serious  side effects.


Comments

Popular posts from this blog

Importance of antineoplastic drug in breast cancer treatment

Fungal ergosterol synthesis inhibitor uses and applications

The Startling Increase in Lung Cancer Cases: A Result of Smog Pollution